Gina Kolata had a recent piece in the NYT that took the CMS Innovation Center to task for not relying on randomized controlled trials more. I respond in a post over at the AcademyHealth blog.
Gina Kolata had a recent piece in the NYT that took the CMS Innovation Center to task for not relying on randomized controlled trials more. I respond in a post over at the AcademyHealth blog.
Aaron E. Carroll, MD, MS is co-Editor-in-Chief of The Incidental Economist and tweets at @aaronecarroll. He is the Chief Health Officer at Indiana University. He is also a Distinguished Professor of Pediatrics and Associate Dean for Research Mentoring at the Indiana University School of Medicine. In addition to contributing regularly to The New York Times and the Atlantic, he is the author of four books, most recently The Bad Food Bible.
Aaron E. Carroll, MD, MS is co-Editor-in-Chief of The Incidental Economist and tweets at @aaronecarroll. He is the Chief Health Officer at Indiana University. He is also a Distinguished Professor of Pediatrics and Associate Dean for Research Mentoring at the Indiana University School of Medicine. In addition to contributing regularly to The New York Times and the Atlantic, he is the author of four books, most recently The Bad Food Bible.
Work posted here under copyright © of the authors • Details on the Site Policies page